Immunocore Holdings (IMCR) Accounts Payables (2022 - 2025)
Historic Accounts Payables for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $23.0 million.
- Immunocore Holdings' Accounts Payables rose 1640.38% to $23.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year increase of 1640.38%. This contributed to the annual value of $25.1 million for FY2024, which is 4102.71% up from last year.
- Latest data reveals that Immunocore Holdings reported Accounts Payables of $23.0 million as of Q3 2025, which was up 1640.38% from $23.9 million recorded in Q2 2025.
- Over the past 5 years, Immunocore Holdings' Accounts Payables peaked at $29.1 million during Q1 2025, and registered a low of $14.4 million during Q4 2022.
- In the last 4 years, Immunocore Holdings' Accounts Payables had a median value of $19.9 million in 2024 and averaged $20.9 million.
- Over the last 5 years, Immunocore Holdings' Accounts Payables had its largest YoY gain of 8776.21% in 2025, and its largest YoY loss of 1640.38% in 2025.
- Immunocore Holdings' Accounts Payables (Quarter) stood at $14.4 million in 2022, then rose by 23.17% to $17.8 million in 2023, then skyrocketed by 41.03% to $25.1 million in 2024, then decreased by 8.54% to $23.0 million in 2025.
- Its Accounts Payables was $23.0 million in Q3 2025, compared to $23.9 million in Q2 2025 and $29.1 million in Q1 2025.